Post-partum haemorrhage (PPH) remains a primary driver of maternal mortality worldwide, reflecting deep systemic failures in obstetric care and emergency response. The human cost is staggering, with approximately 27 million women experiencing excessive bleeding after childbirth annually, resulting in nearly 43,000 deaths. Beyond the immediate loss of life, the condition triggers a cascade of severe morbidity and long-term socioeconomic instability that health systems and finance ministries alike are ill-equipped to absorb.
| Impact Category | Consequences of PPH |
|---|---|
| Clinical Outcomes | Severe anaemia, hysterectomy, organ failure, and long-term psychological trauma |
| Economic Burden | Estimated global cost of $10.4 billion, including emergency care, lost productivity, and long-term disability |
| Intergenerational Impact | Significantly higher mortality rates for infants whose mothers die in childbirth, with knock-on effects for household income, education, and community stability |
Systemic Vulnerabilities in Maternal Care
The prevalence of PPH deaths is not evenly distributed, often mirroring the inequities found in global healthcare infrastructure and public financing. Low- and middle-income countries, particularly in sub-Saharan Africa and South Asia, shoulder a disproportionate share of cases, where gaps in basic emergency obstetric care are compounded by workforce shortages and fragile supply chains.
High-risk scenarios are frequently tied to the lack of skilled attendance at birth or the presence of comorbidities that exacerbate bleeding:
- Environmental Risks: Home births where medical intervention is unavailable or delayed, often due to distance, cost, or cultural barriers.
- Clinical Comorbidities: Pre-existing anaemia or other chronic medical conditions that increase the likelihood and severity of haemorrhage.
- Surgical Complications: Caesarean births, specifically emergency procedures occurring at full cervical dilation, where rapid blood loss can overwhelm under-resourced theatres.
- Institutional Failures: Delivery in healthcare facilities plagued by staffing shortages, inadequate blood banks, and poor resource allocation, where essential medicines or basic monitoring equipment may be unavailable.
The persistence of these deaths points to a failure in quality of care rather than a lack of medical knowledge. Substandard clinical care is “a root cause” of PPH deaths, presenting as “missed or delayed PPH diagnosis, slow and fragmented delivery of treatment interventions, and agonisingly late escalation of care”. For health ministries and regulators, this is less a technical problem than a governance one: how to ensure that agreed standards are consistently implemented at the bedside.
Precision Measurement and the E-MOTIVE Protocol
A critical barrier to saving lives has been the reliance on visual estimation of blood loss, a method that researchers describe as so “grossly inaccurate” that it missed half of PPH cases. In practice, this means that women often cross the threshold into dangerous blood loss long before clinicians formally recognise an emergency.
To counter this, the introduction of the blood collection drape-a low-cost plastic sheet with a measurement pouch-allows for an objective, real-time assessment of blood loss that can be deployed in both hospitals and lower-level facilities. Because the drape is inexpensive and does not require electricity or sophisticated training, it is particularly attractive to governments seeking scalable interventions that fit constrained health budgets.
Under current World Health Organization (WHO) recommendations on postpartum haemorrhage, treatment should be initiated if a woman has lost 500ml of blood, or 300ml if accompanied by abnormal vital signs. When accurate detection using tools such as the drape is paired with the E-MOTIVE response bundle, the progression to life-threatening haemorrhage can be reduced by up to 60%.
The E-MOTIVE framework standardizes the first-response intervention through six critical steps:
- E: Early detection of PPH
- M: Uterine massage
- O: Oxytocic drugs
- T: Tranexamic acid
- V: intraVenous fluids
- E: Examination of the genital tract
For national health authorities, E-MOTIVE offers a ready-made protocol that can be embedded into pre-service training, clinical checklists, and performance monitoring-turning what is currently a variable, clinician-dependent response into a standard operating procedure.
The Challenge of Institutional Implementation
While first-response bundles are effective, the management of life-threatening PPH requires an integrated hospital response. This necessitates “the immediate attendance of the emergency team, which should include senior obstetricians and anaesthetists”. The priority in these acute phases is to “assess and resuscitate the woman through management of her circulation, airway, and breathing. Bleeding should be controlled, and transfusion of blood and blood products should be done if required.”
This level of readiness depends on decisions far upstream from the labour ward: whether health budgets fund sufficient specialist posts; whether blood services are functional; whether procurement systems reliably deliver oxytocin and tranexamic acid; and whether facilities are held accountable against maternal health quality standards set out in national plans and, where applicable, in binding regional commitments.
The transition from evidence-based research to bedside application is where the most significant policy gaps exist. The tools for reduction are available, but they require a systemic shift in how maternal health is governed and financed. In many countries, PPH prevention and response still sit at the margins of broader efforts to strengthen universal health coverage, rather than being treated as a core indicator of system performance.
“The essential knowledge and tools to substantially reduce PPH-related morbidity and mortality now exist; the primary challenge lies in translating this evidence into consistent clinical practice across diverse health-care settings,” as the current research emphasizes. Achieving this will require more than just training; “Success will demand sustained commitment from policy makers and health-care leaders, adequate resource allocation, and continuous quality improvement efforts.” Robust civil registration and health information systems are also critical, so that preventable maternal deaths trigger review, learning, and if needed regulatory response.
Ultimately, the reduction of PPH mortality depends on integrating standardized protocols into national health strategies and maternal health action plans, and aligning them with global commitments such as the targets on maternal mortality embedded in the Sustainable Development Goals. Only when these commitments are backed by clear financing lines, enforceable standards, and routine monitoring will every delivery setting-regardless of its economic status-have the infrastructure to detect and treat haemorrhage before it becomes fatal.
